Yu-Fen Tseng

B-120 Incremental Diagnostic Yield of Next-Generation Sequencing in NSCLC with Wild-Type Results by cobas EGFR Testing and Characterization of Rare EGFR L833V Mutation

EGFR mutation testing is essential for therapeutic decision-making in non–small cell lung cancer (NSCLC). Routine assays primarily detect common EGFR alterations, such as exon 19 deletions and L858R substitutions, but may fail to identify rare or non-classical variants. At National Taiwan University Hospital (NTU...